Stanton S. Marshall's Insider Trades & SAST Disclosures
Stanton S. Marshall's most recent trade in Artivion Inc was a trade of 19,240 Common Stock done . Disclosure was reported to the exchange on March 6, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Stanton S. Marshall.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 19,240 | 117,483 (0%) | 0% | 0 | Common Stock | |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 24.80 per share. | 06 Mar 2025 | 1,603 | 115,880 (0%) | 0% | 24.8 | 39,761 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 18,398 | 98,243 (0%) | 0% | 0 | Common Stock | |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 27.31 per share. | 24 Feb 2025 | 2,299 | 82,233 (0%) | 0% | 27.3 | 62,776 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 27.31 per share. | 24 Feb 2025 | 1,246 | 79,845 (0%) | 0% | 27.3 | 34,023 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 27.31 per share. | 24 Feb 2025 | 672 | 81,091 (0%) | 0% | 27.3 | 18,350 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 27.31 per share. | 24 Feb 2025 | 470 | 81,763 (0%) | 0% | 27.3 | 12,834 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 15.20 per share. | 31 Dec 2024 | 855 | 84,151 (0%) | 0% | 15.2 | 12,996 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 21.63 per share. | 31 Dec 2024 | 381 | 84,532 (0%) | 0% | 21.6 | 8,241 | Common Stock |
| Artivion Inc | Marshall Stanton S. | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 20.39 per share. | 20 Mar 2024 | 2,183 | 83,296 (0%) | 0% | 20.4 | 44,511 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 5,724 | 86,944 (0%) | 0% | 0 | Common Stock | |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 5,724 | 86,985 (0%) | 0% | 0 | Common Stock | |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 18.72 per share. | 01 Mar 2024 | 1,506 | 85,438 (0%) | 0% | 18.7 | 28,195 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 18.72 per share. | 01 Mar 2024 | 1,506 | 85,479 (0%) | 0% | 18.7 | 28,195 | Common Stock |
| Artivion Inc | S. Marshall Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 19.83 per share. | 27 Feb 2024 | 465 | 81,220 (0%) | 0% | 19.8 | 9,223 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 19.83 per share. | 27 Feb 2024 | 465 | 81,261 (0%) | 0% | 19.8 | 9,223 | Common Stock |
| Artivion Inc | S. Stanton Marshall | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 14,800 | 68,703 (0%) | 0% | 0 | Common Stock | |
| Artivion Inc | Stanton Marshall S. | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 10,644 | 83,133 (0%) | 0% | 0 | Common Stock | |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 10,644 | 83,157 (0%) | 0% | 0 | Common Stock | |
| Artivion Inc | S. Marshall Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 5,386 | 74,089 (0%) | 0% | 0 | Common Stock | |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 5,386 | 74,089 (0%) | 0% | 0 | Common Stock | |
| Artivion Inc | Stanton S. Marshall | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 20.27 per share. | 23 Feb 2024 | 1,600 | 72,489 (0%) | 0% | 20.3 | 32,434 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 20.27 per share. | 23 Feb 2024 | 1,576 | 72,513 (0%) | 0% | 20.3 | 31,947 | Common Stock |
| Artivion Inc | Marshall Stanton S. | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 20.27 per share. | 23 Feb 2024 | 1,448 | 81,685 (0%) | 0% | 20.3 | 29,353 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 20.27 per share. | 23 Feb 2024 | 1,431 | 81,726 (0%) | 0% | 20.3 | 29,008 | Common Stock |
| Artivion Inc | S. Marshall Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 10.30 per share. | 31 Dec 2023 | 1,261 | 53,338 (0%) | 0% | 10.3 | 12,991 | Common Stock |
| Artivion Inc | Stanton S. Marshall | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 14.61 per share. | 31 Dec 2023 | 565 | 53,903 (0%) | 0% | 14.6 | 8,255 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 3,663 | 52,984 (0%) | 0% | 0 | Common Stock | |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 13.41 per share. | 01 Mar 2023 | 907 | 52,077 (0%) | 0% | 13.4 | 12,165 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 7,440 | 50,482 (0%) | 0% | 0 | Common Stock | |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 3,770 | 44,218 (0%) | 0% | 0 | Common Stock | |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 12.94 per share. | 23 Feb 2023 | 1,176 | 43,042 (0%) | 0% | 12.9 | 15,215 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 12.94 per share. | 23 Feb 2023 | 1,161 | 49,321 (0%) | 0% | 12.9 | 15,021 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 16.05 per share. | 31 Dec 2022 | 810 | 40,005 (0%) | 0% | 16.0 | 12,999 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 10.30 per share. | 31 Dec 2022 | 443 | 40,448 (0%) | 0% | 10.3 | 4,564 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2022 | 46,630 | 46,630 | - | - | Common Stock | |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2022 | 19,447 | 39,195 (0%) | 0% | 0 | Common Stock | |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 22,334 | 22,334 | - | - | Common Stock | |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 8,406 | 19,748 (0%) | 0% | 0 | Common Stock | |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 2,603 | 12,114 (0%) | 0% | 0 | Common Stock | |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.50 per share. | 17 Feb 2022 | 772 | 11,342 (0%) | 0% | 17.5 | 13,510 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2021 | 8,511 | 9,511 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges